Jubilant Pharmova Ltd.
JUBLPHARMA Share PricePharmaceuticals & Drugs
₹1,067.5
-13 (-1.2%)
As on December 4, 2025
Exchange Scrips: BSE530019NSEJUBLPHARMAISININE700A01033
Market Cap ₹ 16,951 Cr
P/E Ratio 20.09
Dividend Yield 0.47 %
Performance
Market performance
Open1,080.4
High1,090
Volumes84,437
Prev1,067.5
Low1,058.4
As on2025-12-04
Historical performance
1 Year High1,248
3 Year High1,309.9
5 Year High1,309.9
1 Year Low802
3 Year Low268.9
5 Year Low268.9
Fundamentals
Company Valuation
Market Cap (₹Cr)
16,951
Face Value (₹)
1
P/E Ratio
20.09
Dividend Yield
0.47 %
Investment Returns
1 Year
-13%
3 Years
181.8%
5 Years
30%
10 Years
146.6%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,088.94 | Bearish |
| 10-DMA | 1,087.28 | Bearish |
| 20-DMA | 1,106.78 | Bearish |
| 50-DMA | 1,105.98 | Bearish |
| 100-DMA | 1,113.53 | Bearish |
| 200-DMA | 1,056.36 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 11 | 11 | 12 | 12 | 12 |
| Foreign Investors | 2 | 2 | 2 | 2 | 2 |
| Domestic Investors | 9 | 9 | 10 | 10 | 10 |
| Public Investors | 93325 | 99662 | 96514 | 102430 | 89444 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 20.09.
- 3Y Stock Price CAGR of the stock is 41.6.
- The stock has a beta of 0.9.
- In the last financial year, the company had an EBITDA of ₹12305 Million.
- The company generated revenue of ₹72345 Million in the previous financial year.
Jubilant Pharmova Ltd.
1067.5-13 (-1.2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 885745.1
No. of Shares: 830 (Approx)
Performance:-11.4%
P/L: ₹-114254.9
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
